The Pompidou Group’s core mission is to contribute to the development of multidisciplinary, innovative, effective and
evidence-based drug policies in its member states.
It seeks to link Policy, Practice and Science and focuses especially on the realities of local implementation of drug programmes.
The shifting, dynamic nature of the drug phenomenon has required the Group to adapt its role in order to deal with emerging
problems and changes in the drug situation. Flexibility and capacity for innovation are two key attributes that have assisted
the Group in meeting this challenge.
Against an international background characterized by the presence of many European and international bodies working on drugs,
the Pompidou Group provides a multidisciplinary forum at the wider European level where it is possible for policy-makers,
professionals and researchers to discuss and exchange information and ideas on the whole range of drug misuse and trafficking problems.
In order to carry out this mission, it adopts a multidisciplinary, integrated approach to all drug problems and employs a variety
of working methods.
In addition, the Pompidou Group undertakes a bridging role both between EU and non-EU European countries and towards neighbouring
countries in the Mediterranean region.
Because of its links with the Council of Europe it also ensures that policy recommendations are consistent with public
policy as elaborated in other fields of Council work, such as public health, social cohesion and penal policy, with
particular emphasis on ethical issues and respect of Human Rights.
1st meeting of the Expert Group on
“Possible adverse effects and associated cost of
drug control policies”
2015 Plenary meeting of Airport